+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intravenous (IV) Therapy and Vein Access: Global Markets

  • PDF Icon

    Report

  • 164 Pages
  • September 2026
  • Region: Global
  • BCC Research
  • ID: 6290783
Description Jump to:
This report examines the global IV therapy and vein access device market, providing a comprehensive review of applications across various healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. The publisher has analyzed critical market components, including types of intravenous solutions. The report includes segments by product type and application. By product type, the market is segmented into IV solutions and sets, infusion pumps and accessories, and vein access devices (IV catheters). IV solutions and sets are categorized into general IV solutions, parenteral nutrition IV solutions, premixed drug IV solutions, and other IV solutions and sets. Infusion pumps and accessories include general infusion pumps, specialized infusion pumps, and other infusion accessories. Vein access devices cover peripheral intravenous catheters and central venous catheters.

Product inclusions for each IV solution and sets market segment:

  • General IV solutions: Includes normal saline, hypertonic saline, Lactated Ringer’s, Dextran, and dextrose in water used for hydration, fluid replacement, and electrolyte management.
  • Parenteral nutrition IV solutions: Includes intravenous nutritional formulations containing carbohydrates, lipid emulsions, amino acids, vitamins, minerals, and trace elements.
  • Premixed IV solutions: Includes ready-to-administer premixed IV drugs such as antibiotics, pain-management medications, and cardiovascular agents, supplied in IV bags, bottles, or other containers.
  • Other IV solutions and sets: Includes specialized IV solutions not covered above, along with administration sets, extension sets, connectors, filters, and other IV delivery accessories.
This report addresses regulatory aspects, including innovations, technological advances (patents and approvals), and the latest trends, preferences, and developments in IV therapy. It also includes market projections, key companies, and market share analysis for the global IV therapy and vein access market. The scope also includes emerging technologies, such as advanced intraosseous infusion systems, antimicrobial-coated sets, needleless connectors, and smart vein visualization and vascular-access devices, which are expected to improve the safety, efficiency, and reliability of vascular-access procedures. The market has been segmented into major regions, including North America, Asia-Pacific, Europe, and the rest of the world (RoW). The analysis covers countries such as the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, and China.

The report includes:

  • 77 data tables and 68 additional tables 
  • Overview of the global intravenous (IV) therapy and vein access market
  • Analyses of global market trends, with revenue data for 2023-2025, estimates for 2026, and projections of CAGRs through 2031
  • Evaluation of the market by product type, application, and region
  • Discussion of major market drivers, restraints, challenges, and opportunities shaping the adoption of IV therapy and vein access technologies worldwide
  • Review of regulatory frameworks in key countries, along with analysis of macroeconomic factors, Porter’s Five Forces, and the impact of U.S. tariffs on the industry
  • Regional market coverage North America, Europe, Asia-Pacific, the Middle East & Africa, and South America
  • Profiles of leading companies and emerging startups, highlighting their product offerings, business strategies, and recent developments, including BD, Fresenius SE & Co. KGaA, Baxter, B. Braun SE, and Insulet Corp.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of the Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Emerging Technologies
  • Segmental Analysis
  • Regional Analysis
  • Conclusion
Chapter 2 Market Overview
  • Intravenous Therapy Overview
  • Human Circulatory System
  • Definition of Infusion Therapy
  • Definition of Intravenous Therapy
  • Types of IV Infusion
  • Continuous Infusion
  • Intermittent Infusion
  • Patient-Controlled Infusion
  • Methods of IV Infusion Pump
  • Pump Infusion
  • Drip Infusion
  • IV Solutions
  • General IV Solutions
  • Parenteral Nutrition IV Solutions
  • Premixed Drug IV Solutions
  • IV Infusion Pumps
  • Venous Access Devices (IV Catheters)
  • Porter’s Five Forces Analysis of the IV Therapy and Vein Access Market
  • Competitive Rivalry (High)
  • Threat of New Entrants (Moderate)
  • Threat of Substitutes (Low)
  • Bargaining Power of Buyers (High)
  • Bargaining Power of Suppliers (Moderate)
  • Macroeconomic Factors Analysis
  • Inflation and Rising Manufacturing Costs
  • Impact of the U.S.-Israel-Iran Conflict on the Intravenous Therapy and Vein Access Devices Market
  • Slower Global Economic Growth and Capital Spending
  • Government Healthcare Spending and Medical Device Localization
Chapter 3 Market Dynamics
  • Overview
  • Market Drivers
  • Increasing Burden of Chronic Diseases Requiring Long-Term Infusion Therapy
  • Growing Surgical Procedures and Hospital Admissions Driving Vascular Access Demand
  • Rapid Expansion of Home Infusion Therapy
  • Stronger Infection Prevention Guidelines Accelerating Adoption of Advanced Vein Access Technologies
  • Rising Global Burden of VTE and Hospital-Acquired Infections Driving Demand for Advanced IV Therapy and Vein Access Solutions
  • Expanding Global Geriatric Population
  • Market Restraints
  • Risk of Infections and Complications
  • Regulatory Challenges in IV Therapy and Vein Access Market
  • Safety and Recall Challenges in IV Therapy
  • Reimbursement Policies
  • Market Opportunities
  • Technological Advances
  • Expanding Pipeline of Infusion-Based Biologics and Specialty Therapies
Chapter 4 Regulatory Landscape
  • Regulatory Scenario
  • U.S.
  • Europe
  • Japan
  • India
  • China
  • U.K.
Chapter 5 Emerging Trends and Technologies
  • Key Takeaways
  • Advances in Intraosseous Infusion Systems for Vascular Access
  • Antimicrobial-Coated Sets
  • Needleless Connectors
  • IV Filters
  • Smart Vein Visualization and Access Devices
  • Smart IV Devices
  • Blood Transfusion Sets
  • Wireless Sensor Networks (WSN) and AI in IV Therapy
  • Recent Advances in Intravenous Therapy and Vein Access
  • Patent Analysis
  • Key Findings
Chapter 6 Market Segmentation Analysis
  • Segmentation Breakdown
  • Market Analysis by Product Type
  • Key Takeaways
  • IV Solutions and Sets
  • Infusion Pumps and Accessories
  • Vein Access Devices (IV Catheters)
  • Market Analysis by Application
  • Key Takeaways
  • Hospitals
  • Alternative Sites
  • Home-Based
  • Geographic Breakdown
  • Market Analysis by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 7 Competitive Landscape
  • Key Takeaways
  • Industry Scenario
  • Global Market Shares of Leading Companies
  • Acquisitions
  • Strategic Alliances
Chapter 8 Appendix
  • Methodology
  • Sources
  • Abbreviations
Company Profiles
  • ANGIODYNAMICS
  • BAXTER
  • B. BRAUN SE
  • BD
  • CARDINAL HEALTH
  • COOK MEDICAL INC.
  • FRESENIUS SE & CO. KGAA
  • ICU MEDICAL INC.
  • INSULET CORP.
  • IRADIMED CORP.
  • MEDTRONIC
  • PFIZER INC.
  • TERUMO CORP.
  • VYGON
  • WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.
  • Few Emerging Startups/Market Disruptors
List of Tables
Summary Table: Global Market for Intravenous Therapy and Vein Access, by Region, Through 2031
Table 1: Common Examples of General IV Solutions
Table 2: Porter’s Five Forces Analysis: Overview
Table 3: Distribution of Vascular Access Devices Used in Home Infusion Therapy
Table 4: Number and Proportion of Persons Aged 65 Years and Over, by Development Group, 2023 and 2050
Table 5: Major Recalled Products in 2023, FDA
Table 6: Global Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 7: Global Market for IV Solutions and Sets, by Region, Through 2031
Table 8: Global Market for IV Solutions and Sets, by Type, Through 2031
Table 9: Leading Manufacturers/Suppliers of General IV Solutions, 2025
Table 10: Global Market for General IV Solutions, by Region, Through 2031
Table 11: Leading Manufacturers/Suppliers of Parenteral Nutrition IV Solutions, 2025
Table 12: Global Market for Parenteral Nutrition IV Solutions, by Region, Through 2031
Table 13: Leading Manufacturers/Suppliers of Premixed Drug IV Solutions, 2025
Table 14: Global Market for Premixed Drug IV Solutions, by Region, Through 2031
Table 15: Global Market for Other IV Solutions and Sets, by Region, Through 2031
Table 16: Global Market for Infusion Pumps and Accessories, by Region, Through 2031
Table 17: Global Market for Infusion Pumps and Accessories, by Type, Through 2031
Table 18: Leading Manufacturers/Suppliers of Ambulatory/Disposable Infusion Pumps, 2025
Table 19: Leading Manufacturers/Suppliers of Insulin Infusion Pumps, 2025
Table 20: Leading Manufacturers/Suppliers of PCA Infusion Pumps, 2025
Table 21: Leading Manufacturers/Suppliers of Enteral Feeding Pumps, 2025
Table 22: Leading Manufacturers/Suppliers of Implantable Infusion Pumps, 2025
Table 23: Global Market for Specialized Infusion Pumps, by Region, Through 2031
Table 24: Global Market for Specialized Infusion Pumps, by Type, Through 2031
Table 25: Global Market for Other Infusion Accessories, by Region, Through 2031
Table 26: Leading Manufacturers/Suppliers of Large Volume Infusion Pumps, 2025
Table 27: Leading Manufacturers/Suppliers of Syringe Infusion Pumps, 2025
Table 28: Global Market for General Infusion Pumps, by Region, Through 2031
Table 29: Global Market for General Infusion Pumps, by Type, Through 2031
Table 30: Global Market for Vein Access Devices (IV Catheters), by Region, Through 2031
Table 31: Global Market for Vein Access Devices (IV Catheters), by Type, Through 2031
Table 32: Leading Manufacturers/Suppliers of Peripheral IV Catheters, 2025
Table 33: Global Market for Peripheral IV Catheters, by Region, Through 2031
Table 34: Leading Manufacturers/Suppliers of Central Venous Catheters (CVC), 2025
Table 35: Global Market for Central Venous Catheters (CVCS), by Region, Through 2031
Table 36: Global Market for IV Therapy and Vein Access, by Application, Through 2031
Table 37: Global Market for IV Therapy and Vein Access in Hospitals, by Region, Through 2031
Table 38: Barriers and Facilitators to the Uptake of IV Therapies in Ambulatory Patients, 2024
Table 39: Global Market for IV Therapy and Vein Access in Alternative Sites, by Region, Through 2031
Table 40: Global Market for IV Therapy and Vein Access in Home-Based Care, by Region, Through 2031
Table 41: Global Market for IV Therapy and Vein Access, by Region, Through 2031
Table 42: North American Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 43: North American Market for IV Solutions and Sets, by Type, Through 2031
Table 44: North American Market for Infusion Pumps and Accessories, by Type, Through 2031
Table 45: North American Market for Vein Access Devices (IV Catheters), by Type, Through 2031
Table 46: North American Market for IV Therapy and Vein Access, by Application, Through 2031
Table 47: North American Market for IV Therapy and Vein Access, by Country, Through 2031
Table 48: U.S. Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 49: Canadian Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 50: Mexican Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 51: European Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 52: European Market for IV Solutions and Sets, by Type, Through 2031
Table 53: European Market for Infusion Pumps and Accessories, by Type, Through 2031
Table 54: European Market for Vein Access Devices (IV Catheters), by Type, Through 2031
Table 55: European Market for IV Therapy and Vein Access, by Application, Through 2031
Table 56: European Market for IV Therapy and Vein Access, by Country, Through 2031
Table 57: German Market for IV Therapy and Vein Access, by Product Type, Through 2029
Table 58: U.K. Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 59: French Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 60: Italian Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 61: Spanish Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 62: Rest of the Europe Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 63: Asia-Pacific Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 64: Asia-Pacific Market for IV Solutions and Sets, by Type, Through 2031
Table 65: Asia-Pacific Market for Infusion Pumps and Accessories, by Type, Through 2031
Table 66: Asia-Pacific Market for Vein Access Devices (IV Catheters), by Type, Through 2031
Table 67: Asia-Pacific Market for IV Therapy and Vein Access, by Application, Through 2031
Table 68: Asia-Pacific Market for IV Therapy and Vein Access, by Country, Through 2031
Table 69: Chinese Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 70: Indian Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 71: Japanese Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 72: South Korean Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 73: Approved Substitute Overseas-Registered IV Fluids Under Section 19A of the Therapeutic Goods Act 1989 for 2025
Table 74: Australian Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 75: Rest of Asia-Pacific Market for IV Therapy and Vein Access, by Product Type, Through 2029
Table 76: RoW Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 77: RoW Market for IV Solutions and Sets, by Type, Through 2031
Table 78: RoW Market for Infusion Pumps and Accessories, by Type, Through 2031
Table 79: RoW Market for Vein Access Devices (IV Catheters), by Type, Through 2031
Table 80: RoW Market for IV Therapy and Vein Access, by Application, Through 2031
Table 81: RoW Market for IV Therapy and Vein Access, by Sub-Region, Through 2031
Table 82: South American Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 83: MEA Market for IV Therapy and Vein Access, by Product Type, Through 2031
Table 84: Leading Manufacturers in the IV Therapy and Vein Access Market, 2025
Table 85: Acquisitions in IV Therapy and Vein Access Market, 2022-2025
Table 86: Major Strategic Alliances in the Intravenous Therapy and Vein Access Market, 2023-2026
Table 87: Information Sources in This Report
Table 88: Abbreviations Used in This Report
Table 89: AngioDynamics: Company Snapshot
Table 90: AngioDynamics: Financial Performance, FY 2024 and 2025
Table 91: AngioDynamics: Product Portfolio
Table 92: AngioDynamics: News/Key Developments, 2023-2024
Table 93: Baxter: Company Snapshot
Table 94: Baxter: Financial Performance, FY 2024 and 2025
Table 95: Baxter: Product Portfolio
Table 96: Baxter: News/Key Developments, 2024-2026
Table 97: B. Braun SE: Company Snapshot
Table 98: B. Braun SE: Financial Performance, FY 2024 and 2025
Table 99: B. Braun SE: Product Portfolio
Table 100: B. Braun SE: News/Key Developments, 2023-2026
Table 101: BD: Company Snapshot
Table 102: BD: Financial Performance, FY 2024 and 2025
Table 103: BD: Product portfolio
Table 104: BD: News/Key Developments, 2023-2025
Table 105: Cardinal Health: Company Snapshot
Table 106: Cardinal Health: Financial Performance, FY 2023 and 2024
Table 107: Cardinal Health: Product Portfolio
Table 108: Cardinal Health: News/Key Developments, 2024-2025
Table 109: Cook Medical Inc.: Company Snapshot
Table 110: Cook Medical Inc.: Product Portfolio
Table 111: Cook Medical Inc.: News/Key Developments, 2024
Table 112: Fresenius SE & Co. KGaA: Company Snapshot
Table 113: Fresenius SE & Co. KGaA: Financial Performance, FY 2024 and 2025
Table 114: Fresenius SE & Co. KGaA: Product Portfolio
Table 115: Fresenius SE & Co. KGaA: News/Key Developments, 2023-2026
Table 116: ICU Medical Inc.: Company Snapshot
Table 117: ICU Medical Inc.: Financial Performance, FY 2024 and 2025
Table 118: ICU Medical Inc.: Product Portfolio
Table 119: ICU Medical Inc.: News/Key Developments, 2023-2024
Table 120: Insulet Corp.: Company Snapshot
Table 121: Insulet Corp.: Financial Performance, FY 2024 and 2025
Table 122: Insulet Corp.: Product Portfolio
Table 123: Insulet Corp.: News/Key Developments, 2023-2025
Table 124: IRadimed Corp.: Company Snapshot
Table 125: IRadimed Corp.: Financial Performance, FY 2024 and 2025
Table 126: IRadimed Corp.: Product Portfolio
Table 127: IRadimed Corp.: News/Key Developments, 2023-2025
Table 128: Medtronic: Company Snapshot
Table 129: Medtronic: Financial Performance, FY 2024 and 2025
Table 130: Medtronic: Product Portfolio
Table 131: Medtronic: News/Key Developments, 2023-2025
Table 132: Pfizer Inc.: Company Snapshot
Table 133: Pfizer Inc.: Financial Performance, FY 2024 and 2025
Table 134: Pfizer Inc.: Product Portfolio
Table 135: Pfizer Inc.: News/Key Developments, 2023-2024
Table 136: Terumo Corp.: Company Snapshot
Table 137: Terumo Corp.: Financial Performance, FY 2024 and 2025
Table 138: Terumo Corp.: Product Portfolio
Table 139: Terumo Corp.: News/Key Developments, 2023-2025
Table 140: Vygon: Company Snapshot
Table 141: Vygon: Product Portfolio
Table 142: Wellmed International Industries Pvt. Ltd.: Company Snapshot
Table 143: Wellmed International Industries Pvt. Ltd.: Product Portfolio
Table 144: List of a Few Emerging Startups/Market Disruptors
List of Figures
Summary Figure: Global Market Shares for Intravenous Therapy and Vein Access, by Region, 2025
Figure 1: Porter’s Five Forces Analysis: Global IV Therapy and Vein Access Market
Figure 2: Market Dynamics of IV Therapy and Vein Access
Figure 3: Patents Documented, by Top Owners, January 2025 to June 2026
Figure 4: Documented Patent Shares, by Jurisdiction, January 2025 to June 2026
Figure 5: Patent Shares for Surgical Devices, by Type, January 2025 to June 2026
Figure 6: Global Market Shares for IV Therapy and Vein Access, by Product Type, 2025
Figure 7: Global Market Shares for IV Solutions and Sets, by Type, 2025
Figure 8: Global Market Shares for Infusion Pumps and Accessories, by Type, 2025
Figure 9: Global Market Shares for Vein Access Devices (IV Catheters), by Type, 2025
Figure 10: Global Market Shares for IV Therapy and Vein Access, by Application, 2025
Figure 11: Global Market Shares for IV Therapy and Vein Access, by Region, 2025
Figure 12: Global Market Shares for IV Therapy and Vein Access, by Leading Companies, 2025
Figure 13: AngioDynamics: Revenue Shares, by Business Unit, FY 2025
Figure 14: AngioDynamics: Revenue Shares, by Country/Region, FY 2025
Figure 15: Baxter: Revenue Shares, by Business Unit, FY 2025
Figure 16: Baxter: Revenue Shares, by Country/Region, FY 2025
Figure 17: B. Braun SE: Revenue Shares, by Business Unit, FY 2025
Figure 18: B. Braun SE: Revenue Shares, by Country/Region, FY 2025
Figure 19: BD: Revenue Shares, by Business Unit, FY 2025
Figure 20: BD: Revenue Shares, by Country/Region, FY 2025
Figure 21: Cardinal Health: Revenue Shares, by Business Unit, FY 2024
Figure 22: Cardinal Health: Revenue Shares, by Country/Region, FY 2024
Figure 23: Fresenius SE & Co. KGaA: Revenue Shares, by Business Unit, FY 2025
Figure 24: Fresenius SE & Co. KGaA: Revenue Shares, by Country/Region, FY 2025
Figure 25: ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 26: ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 27: Insulet Corp.: Revenue Shares, by Business Unit, FY 2025
Figure 28: Insulet Corp.: Revenue Shares, by Country/Region, FY 2025
Figure 29: IRadimed Corp.: Revenue Shares, by Business Unit, FY 2025
Figure 30: IRadimed Corp.: Revenue Shares, by Country/Region, FY 2025
Figure 31: Medtronic: Revenue Shares, by Business Unit, FY 2024
Figure 32: Medtronic: Revenue Shares, by Country/Region, FY 2024
Figure 33: Pfizer Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 34: Pfizer Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 35: Terumo Corp.: Revenue Shares, by Business Unit, FY 2025
Figure 36: Terumo Corp.: Revenue Shares, by Country/Region, FY 2025

Executive Summary

The global market for intravenous (IV) therapy and vein access is expected to grow from $49.5 billion in 2026 and is projected to reach $67.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2026 to 2031.

Companies Mentioned

  • ANGIODYNAMICS
  • BAXTER
  • B. BRAUN SE
  • BD
  • CARDINAL HEALTH
  • COOK MEDICAL INC.
  • FRESENIUS SE & CO. KGAA
  • ICU MEDICAL INC.
  • INSULET CORP.
  • IRADIMED CORP.
  • MEDTRONIC
  • PFIZER INC.
  • TERUMO CORP.
  • VYGON
  • WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.

Related Topics

Related Reports

Intravenous (IV) Therapy and Vein Access Market - Product Image

Intravenous (IV) Therapy and Vein Access Market

  • Report
  • 148 Pages
  • Global
From
Intravenous Therapy and Vein Access Devices Market Report 2026 - Product Image

Intravenous Therapy and Vein Access Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Intravenous Therapy and Vein Access - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Intravenous Therapy and Vein Access - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 140 Pages
  • Global
From
Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2026-2034 - Product Image

Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2026-2034

  • Report
  • 145 Pages
  • Global
From
Intravenous Therapy and Vein Access - Global Strategic Business Report - Product Image

Intravenous Therapy and Vein Access - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.